Algernon Pharmaceuticals Inc (AGNPF)

[medchem]

That's not exactly how it works. The data is reviewed in professional fashion by statisticians and associated scientists. The data is reported in a objective way by the company: i.e. they will report if there was or was not statistical significance with respect to the primary and second disease outcomes. These outcomes are reported on the clinical trials .gov website which is freely available.

Then... later... Dr. Williams will probably have a press release giving his opinion on things... but... if the data is good, he will say "moving forward to phase 3"... if it's bad... "drug doesn't work, so we will just continue with chronic cough/IPF"